https://orcid.org/0000-0001-6812-178X
References
- Tok PSK, Kamarudin N, Jamaludin M, et al. Effect of COVID-19 on tuberculosis notification in Johor bahru, Malaysia. Infect Dis. 2022;54(3):235–237.
- World Health Organization. Handbook for the use of digital technologies to support tuberculosis medication adherence. WHO/HTM/TB2017.30
- Garfein RS, Doshi RP. Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support. J Clin Tuberc Other Mycobact Dis. 2019;17:100098.
- Ravenscroft L, Kettle S, Persian R, et al. Video-observed therapy and medication adherence for tuberculosis patients: randomised controlled trial in Moldova. Eur Respir J. 2020;56(2):2000493.
- Bendiksen R, Ovesen T, Asfeldt AM, et al. Use of video directly observed treatment for tuberculosis in Northern Norway. Tidsskr Nor Laegeforen. 2020;140(1)
- Truong CB, Tanni KA, Qian J. Video-Observed therapy versus directly observed therapy in patients with tuberculosis. Am J Prev Med. 2022;62(3):450–458.
- Sekandi JN, Buregyeya E, Zalwango S, et al. Video directly observed therapy for supporting and monitoring adherence to tuberculosis treatment in Uganda: a pilot cohort study. ERJ Open Res. 2020;6(1):00175–2019.
- Sinkou H, Hurevich H, Rusovich V, et al. Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience. Eur Respir J. 2017;49(3):1602049.
- Story A, Aldridge RW, Smith CM, et al. Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial. Lancet. 2019;393(10177):1216–1224.
- Perry A, Chitnis A, Chin A, et al. Real-world implementation of video-observed therapy in an urban TB program in the United States. Int J Tuberc Lung Dis. 2021;25(8):655–661.